MENU

My 3 winners from reporting season so far

We’re over halfway through reporting season and there have been a number of interesting results. Most of them were expected but I think a few of them were impressive to me.

Exciting results

CSL Limited (ASX: CSL)

I was very impressed by CSL’s result, considering how large the healthcare giant already is. It managed to grew revenue by 13% and earnings per share (EPS) by 36% whilst still investing heavily for the future.

It’s the investing for the future which I believe is impressive and speaks volumes about how good of a long­-term investment it has been and will be.

CSL is trading fairly expensively now but I’d say it’s the one stock in the ASX20 which deserves the high valuation.

Insurance Australia Group (ASX: IAG)

I don’t generally like insurance companies as investments, but Insurance Australia Group has shown it can deliver the goods. I thought it was a particularly good result in light of how poorly Suncorp Group Ltd (ASX: SUN) did with its profit report.

Warren Buffett, or his command team, must have seen something they really liked for Berkshire Hathaway to take a stake. It has paid off with insurance profits up 30% and cash net profit after tax up 31.5%.

It’s still a good-looking dividend option and could yet beat the market.

Breville Group Ltd (ASX: BRG)

I love it when a company delivers a decent result, but it completely beats the market’s expectations. Breville only grew revenue by 13.6% and underlying profit by 12.4%, yet its share price has grown by 14% over the past five days.

To me, it doesn’t seem the type of company that can beat the market, yet it’s more than doubled since its low in 2016 and grown by more than 2,750% since its GFC low.

Foolish takeaway

I was impressed by all three, but that doesn’t mean they’re all buys at today’s prices. In-fact, it could be worth selling them due to how high the share prices have gone.

Instead, it could be much better to redeploy your money into these top stocks.

Top 3 ASX Blue Chips To Buy In 2018

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Insurance Australia Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.